Dajani AS, Bisno AL, Chung KJ, Durack DT, Freed M, Gerber MA, Karchmer AW, Millard HD, Rahimtoola S, Shulman ST, Watanaku- nakorn C, Taubert KA. Prevention of bacterial endocarditis: recommen- dations by the American Heart Association. JAMA. 1990;264: 2919 2922. 14. Selton-Suty C, Duval X, Brochet E, Doco-Lecompte T, Hoen B, Delahaye E, Leport C, Danchin N. New French recommendations for the prophylaxis of infectious endocarditis [in French]. Arch Mal Coeur Vaiss. 2004;97:626 631. 15. Gould FK, Elliott TS, Foweraker J, Fulford M, Perry JD, Robert GJ, Sandoe JA, Watkin RW. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy: authors response. J Antimicrob Chemother. 2006;57: 1035 1042. 16. Ashrafian H, Bogle RG. Antimicrobial prophylaxis for endocarditis: emotion or science? Heart. 2007;93:5 6. 17. Burnette-Curley D, Wells V, Viscount H, Munro CL, Fenno JC, Fives- Taylor P, Macrina FL. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun. 1995;63: 4669 4674. 18. Viscount HB, Munro CL, Burnette-Curley D, Peterson DL, Macrina FL. Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect Immun. 1997;65:994 1002. 19. Kitten T, Munro CL, Wang A, Macrina FL. Vaccination with FimA from Streptococcus parasanguis protects rats from endocarditis caused by other viridans streptococci. Infect Immun. 2002;70:422 425. 20. Durack DT, Beeson PB. Experimental bacterial endocarditis, II: survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972;53:50 53. 21. Fowler VG, Scheld WM, Bayer AS. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practices of Infectious Diseases. Philadelphia, Pa: Elsevier Churchill Livingstone; 2005:975 1021. 22. Osler W. Gulstonian lectures on malignant endocarditis. lecture I, and lecture II Lancet. 1885;1:415 418, 459 464. 23. Okell CC, Elliott SD. 